OmniComm Penetrates Growing Israeli Life Sciences Market

Article

OmniComm has announced the signing of an agreement with Medistat Ltd.

OmniComm has announced the signing of an agreement with Medistat Ltd., headquartered in Tel Aviv, Israel; to address the clinical trial needs of the growing Israeli life sciences sector.   Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.